GERN Stock Analysis: Buy, Sell, or Hold?
GERN - Geron Corp
$1.24
-0.05 (-4.26%)
▼
5d:
-11.15%
30d:
-26.49%
90d:
-31.39%
HOLD
MODERATE Confidence
Analysis Updated: May 18, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Smart Money Accumulation
GERN is down 7.2% this week, but smart money is accumulating calls. Top strike: $1.5 2026-06-18 with 1,966 OI. Call ratio: 69% View Scanner →
Strength: 5.5/10
Get Alerted When GERN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called GERN this week
75% bullish • 1 bearish
75% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GERN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: GERN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: GERN is currently trading at $1.24, which is considered oversold relative to its 30-day fair value range of $1.40 to $1.67. From a valuation perspective, the stock is trading at a discount (Forward PE: 18.4) compared to its historical average (21.2). Remarkably, the market is currently pricing in an annual earnings decline of 4.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, GERN is in a downtrend. The price is currently testing key support at $1.24. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.3% recently.
Market Sentiment: GERN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.40 (+163.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GERN is in a downtrend. The price is currently testing key support at $1.24. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.3% recently.
Market Sentiment: GERN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.40 (+163.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.40 -
$1.67
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
Protect Your Profits
Holding GERN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.3%)
- BULLISH: Trading 163.6% below Wall St target ($3.40)
- CAUTION: 5-day price weakness (-11.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.40 -
$1.67
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.24
Resistance Level
$1.73
Current Trend
Downtrend
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.43
Wall Street Target
$3.40
(+163.6%)
Revenue Growth (YoY)
30.9%
Profit Margin
-34.3%
Valuation Discount vs History
-4.5% cheaper
PE vs Historical
18.4 vs 21.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.5%
(market-implied from PE analysis)
1-Year Target
$1.23
(-5%)
2-Year Target
$1.18
(-9%)
3-Year Target
$1.12
(-13%)
3-Yr Target (if PE normalizes)
(PE: 18→21)
$1.29
(+0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.4 to 21.2
Stabilization Target:
$1.48
(+15.0%)
PE Expansion Potential:
+15.0%
Share & Embed Analysis
Last updated: May 18, 2026 2:47 PM ET
Data refreshes hourly during market hours. Next update: 3:47 PM
Data refreshes hourly during market hours. Next update: 3:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GERN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 45 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$242 | 64 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 53 HOLD |
Advanced GERN Option Strategies
Professional options setups generated by AI based on today's GERN price and gamma walls.
